BioLineRx
BLRX
$0.62
Share price
-4.88%
Change (1 day)
-54.93%
Change (1 year)
Categories
Market capitalization of BioLineRx (BLRX)
Market cap: $49.72 Million
As of May 2024 BioLineRx has a market cap of $49.72 Million. This makes BioLineRx the world's 7758th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of BioLineRx from 2011 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $49.72 M | -54.44% |
| 2023 | $0.10 B | 197.66% |
| 2022 | $36.66 M | -63.13% |
| 2021 | $99.42 M | 66.18% |
| 2020 | $59.83 M | 124.85% |
| 2019 | $26.6 M | -46.6% |
| 2018 | $49.83 M | -56.49% |
| 2017 | $0.11 B | 124.67% |
| 2016 | $50.98 M | -29.04% |
| 2015 | $71.84 M | 11.06% |
| 2014 | $64.69 M | -5% |
| 2013 | $68.09 M | 47.16% |
| 2012 | $46.27 M | 18.1% |
| 2011 | $39.18 M |
End of Day market cap according to different sources
On May 13th, 2024 the market cap of BioLineRx was reported to be:
$49.72 Million
$49.72 Million
$45.35 Million
$51.12 Million